STING agonist LNP delivered therapy (University Of Pennsylvania)

N/A

Report date: 2025/05/22 17:22:43

Base Information

Drug NameSTING agonist LNP delivered therapy (University Of Pennsylvania)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > mRNA
Mechanisms of ActionStimulator of interferon genes agonists
TargetsStimulator of interferon genes
Therapy Area/IndicationsCarcinoma, Pancreatic DuctalCarcinoma, Merkel Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pennsylvania
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Pennsylvania
Inactive CompaniesN/A
Active IndicationsCarcinoma, Pancreatic DuctalCarcinoma, Merkel Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A